WO2005116854A3 - Verfahren zur (zweistufigen) dosis- und dosierungsfindung - Google Patents

Verfahren zur (zweistufigen) dosis- und dosierungsfindung Download PDF

Info

Publication number
WO2005116854A3
WO2005116854A3 PCT/EP2005/005315 EP2005005315W WO2005116854A3 WO 2005116854 A3 WO2005116854 A3 WO 2005116854A3 EP 2005005315 W EP2005005315 W EP 2005005315W WO 2005116854 A3 WO2005116854 A3 WO 2005116854A3
Authority
WO
WIPO (PCT)
Prior art keywords
dosing
finding
dosage
dosage finding
agrochemicals
Prior art date
Application number
PCT/EP2005/005315
Other languages
English (en)
French (fr)
Other versions
WO2005116854A2 (de
Inventor
Bernhard Knab
Joerg Lippert
Roland Loosen
Andreas Schuppert
Michael Sevestre
Juri Solodenko
Stefan Willmann
Original Assignee
Bayer Technology Services Gmbh
Bernhard Knab
Joerg Lippert
Roland Loosen
Andreas Schuppert
Michael Sevestre
Juri Solodenko
Stefan Willmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Technology Services Gmbh, Bernhard Knab, Joerg Lippert, Roland Loosen, Andreas Schuppert, Michael Sevestre, Juri Solodenko, Stefan Willmann filed Critical Bayer Technology Services Gmbh
Priority to EP05750073A priority Critical patent/EP1759324A2/de
Priority to JP2007513744A priority patent/JP2008505377A/ja
Priority to US11/569,449 priority patent/US20070253903A1/en
Publication of WO2005116854A2 publication Critical patent/WO2005116854A2/de
Publication of WO2005116854A3 publication Critical patent/WO2005116854A3/de

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures

Landscapes

  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Computing Systems (AREA)
  • Theoretical Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Die Erfindung betrifft ein Verfahren zur Dosierung von spezifischen Dosen und zeitlichen Dosierungsmuster Dosierungsprofilen von Arzneistoffen (bei Tieren und Menschen) sowie Agrochemikalien (bei der Behandlung von Pflanzen).
PCT/EP2005/005315 2004-05-25 2005-05-14 Verfahren zur (zweistufigen) dosis- und dosierungsfindung WO2005116854A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP05750073A EP1759324A2 (de) 2004-05-25 2005-05-14 Verfahren zur (zweistufigen) dosis- und dosierungsfindung
JP2007513744A JP2008505377A (ja) 2004-05-25 2005-05-14 （２段階）投薬及び投薬決定のための方法
US11/569,449 US20070253903A1 (en) 2004-05-25 2005-05-14 Method for (Two-Step) Dosing and Dosage Finding

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004025534A DE102004025534A1 (de) 2004-05-25 2004-05-25 Verfahren zur (zweistufigen) Dosis- und Dosierungsfindung
DE102004025534.2 2004-05-25

Publications (2)

Publication Number Publication Date
WO2005116854A2 WO2005116854A2 (de) 2005-12-08
WO2005116854A3 true WO2005116854A3 (de) 2006-12-28

Family

ID=35404398

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/005315 WO2005116854A2 (de) 2004-05-25 2005-05-14 Verfahren zur (zweistufigen) dosis- und dosierungsfindung

Country Status (5)

Country Link
US (1) US20070253903A1 (de)
EP (1) EP1759324A2 (de)
JP (1) JP2008505377A (de)
DE (1) DE102004025534A1 (de)
WO (1) WO2005116854A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005028080A1 (de) * 2005-06-17 2006-12-21 Bayer Technology Services Gmbh Verfahren zur zeitlich gesteuerten intravenösen Verabreichung des Narkosemittels Propofol
DE102006028232A1 (de) * 2006-06-20 2007-12-27 Bayer Technology Services Gmbh Vorrichtung und Verfahren zur Berechnung und Bereitstellung einer Medikamentendosis
RU2446843C2 (ru) * 2006-08-01 2012-04-10 Конинклейке Филипс Электроникс, Н.В. Планирование биологически направляемой адаптивной терапии
EP2668945A1 (de) 2012-06-01 2013-12-04 Bayer Technology Services GmbH Genotyp- bzw. Phänotyp-basierte Arzeimittelformulierungen
US8554712B1 (en) 2012-12-17 2013-10-08 Arrapoi, Inc. Simplified method of predicting a time-dependent response of a component of a system to an input into the system
EP3027763B1 (de) * 2013-07-29 2018-05-30 The Regents of The University of California Steuerungstechnologieplattform für ein echtzeit-feedback-system mit dynamisch wechselnden stimulationen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08299706A (ja) * 1995-05-09 1996-11-19 Fujita Corp 濁水処理システム
US6647358B2 (en) * 1998-09-14 2003-11-11 Lion Bioscience Ag Pharmacokinetic-based drug design tool and method
US20030087869A1 (en) * 2001-09-28 2003-05-08 Ebens Allen James Assay for compounds affecting invertebrate cell secretory pathways
US20040138826A1 (en) * 2002-09-06 2004-07-15 Carter Walter Hansbrough Experimental design and data analytical methods for detecting and characterizing interactions and interaction thresholds on fixed ratio rays of polychemical mixtures and subsets thereof
AU2003260191B2 (en) * 2002-09-20 2009-10-01 Neurotech Research Pty Limited Condition analysis

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BALANT L P ET AL: "Modelling during drug development", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, vol. 50, no. 1, 3 July 2000 (2000-07-03), pages 13 - 26, XP004257177, ISSN: 0939-6411 *
DERENDORF H ET AL: "Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives.", PHARMACEUTICAL RESEARCH. FEB 1999, vol. 16, no. 2, February 1999 (1999-02-01), pages 176 - 185, XP002383973, ISSN: 0724-8741 *
MEIBOHM B AND DERENDORF H ET AL: "Pharmacokinetics/Pharmacodynamic studies in drug product development", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION. WASHINGTON, US, vol. 91, no. 1, January 2002 (2002-01-01), pages 18 - 31, XP002989693, ISSN: 0022-3549 *
WILLMANN S ET AL: "PK-Sim(R): a physiologically based pharmacokinetic 'whole-body' model", BIOSILICO, ELSEVIER, vol. 1, no. 4, 4 September 2003 (2003-09-04), pages 121 - 124, XP004886543, ISSN: 1478-5382 *

Also Published As

Publication number Publication date
DE102004025534A1 (de) 2005-12-15
WO2005116854A2 (de) 2005-12-08
EP1759324A2 (de) 2007-03-07
JP2008505377A (ja) 2008-02-21
US20070253903A1 (en) 2007-11-01

Similar Documents

Publication Publication Date Title
WO2007081949A3 (en) Small-volume oral transmucosal dosage forms
IL190951A0 (en) Method of acting upon organism by targeted delivery of biologicaly active substances into mitochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
WO2007002597A3 (en) Modified-release formulations of a bupropion salt
WO2007103510A3 (en) Methods, dosing regimens & medications using anti-progestational agents for the treatment of disorders
WO2008157103A3 (en) Modified release solid or semi-solid dosage forms
WO2005041925A3 (en) Compositions and dosage forms for enhanced absorption
WO2007070052A3 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
WO2007081521A3 (en) Salts of potassium atp channel openers and uses thereof
WO2008021113A3 (en) Transdermal methods and systems for treating alzheimer's disease
WO2007112453A3 (en) Methods amd compositions for treating conditions
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
WO2005097076A3 (en) Low dose pharmaceutical products
WO2005116854A3 (de) Verfahren zur (zweistufigen) dosis- und dosierungsfindung
WO2006084911A3 (en) Improved device for application of medicaments, manufacturing method therefor, and method of treatment
WO2007123511A3 (en) Dosing regimens for the treatment of cancer
DK2043637T3 (da) Fremgangsmåder og medikamenter til administrering af ibuprofen
EP1731609A4 (de) Rad51-expressionsinhibitor, den inhibitor als wirkstoff enthaltender arzneistoff und nutzung davon
WO2008012796A3 (en) Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation
UA96622C2 (ru) Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования
WO2005117913A3 (en) Ozonized pharmaceutical composition and method
WO2009012472A3 (en) Methods and compositions for treating conditions
NO20081147L (no) Marrubiin og preparat for redusering av snorking, forpakning og metode
WO2008049801A3 (en) Agrochemical composition and method for treating plants comprising administration of said composition
WO2008027880A3 (en) Strontium-based treatment of otosclerosis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005750073

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007513744

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 11569449

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2005750073

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 11569449

Country of ref document: US